29
May 2015Genelux Announces Positive Phase 1 Data for Viral-Based Cancer Therapy
Genelux is exploring the area of cancer virotherapy, where one disease is harnessed and used to attack another, with GL-ONC1.
29
May 2015Onxeo annonce des données précliniques et cliniques de 3 études qui confirment le potentiel de belinostat dans plusieurs indications de cancers orphelins – France Biotech
L’association a pour but de promouvoir le développement de l’industrie des biotechnologies et des sciences de la vie en France
29
May 2015CAR-T powerhouse Juno allies with gene-editing upstart Editas in $737M deal
One of the leaders of the CAR-T revolution has now aligned itself in an R&D collaboration with one of the top biotechs to emerge in the hot gene editing field.
28
May 2015HIV biotech Calimmune bags $15M to move one-time gene therapy into new trials
After getting started 9 years ago with backing from angel investors, Calimmune just landed a $15 million B round, positioning the biotech to move into the clinic with a gene therapy designed to durably stymie the lethal HIV with one treatment.
28
May 2015A la une – Mulhouse : partenariat dans les biotechs – e-alsace
Rhenovia Pharma, une société biotechnologique fondée en 2007 à Mulhouse (68), et Optivia Biotechnology ont annoncé la signature d’un accord de partenariat.
27
May 2015Last days for the Early Bird for Innovation Days 2015 !
Last days of early birds for the Innovation Days 2015, which will be held October 5&6 at the Cite Universitaire in Paris. Strategic Alliances, Open Innovation and eHealth are the key themes of this 6th edition of interactive conferences held by recognized experts. You will also gain the advantage of the new partnering partnering platform which will increase your business opportunities during the event !…
27
May 2015Chinese biotech 3SBIO launches up to $712 mln HK IPO
* 3SBIO offers 484.9 mln new shares, CITIC PE 121.2 mlnshares* Company launches HK IPO two years after delisting fromNasdaq* IPO set for June 4 pricing, debut on June 11 (Adds breakdown of IPO shares,
27
May 2015Biotech stocks are way up—but the boom may just be starting
Forget fears of a biotech bubble. This time there are good reasons for the sector’s gains: Ideas that inflated the first bubble are now becoming products.
26
May 2015Le Campus Biotech ambitionne de devenir “le CERN du cerveau”
Romandie.com, soyez informé avant les journalistes ! News suisses et internationales. Info brute à forte valeur ajoutée
26
May 2015Le Journal des entreprises – Normandie – Biosims. La biotech Normande lève à nouveau 1 M€
Biosims. La biotech Normande lève à nouveau 1 M€ – La biotech rouennaise annonce avoir finalisé une seconde levée de fonds de 1 million d’euros auprès de GO Capital et de business angels locaux. La biotech implantée à Rouen, spécialisée dans les…